Skip to main content
. 2018 Mar 20;41(3):125–129. doi: 10.1097/CJI.0000000000000208

FIGURE 3.

FIGURE 3

The LM-MRB prime-boost improves efficacy. A, Tumor growth analysis of B16F10-Ova tumor-bearing animals that received LM, MRB, or LM and MRB (n=6) or (B) Ad and MRB or LM and MRB (n=10). C, Survival curves obtained from (B). D, Long-term survivors (n=5) (123 or 314 d) from LM-Ova-MRB-Ova prime-boost experiments were rechallenged with E0771 cells and B16F10-Ova cells on opposite flanks. The graph shows the percentage of mice that displayed tumors of each type. E, Mouse weight over time (n=10). Ad indicates adenovirus; LM, Listeria monocytogenes; MRB, Maraba; Ova, ovalbumin.